Literature DB >> 2124977

Host and tumour factors in cancer metastasis.

I J Fidler1.   

Abstract

The process of cancer metastasis is sequential and selective and contains stochastic elements. The growth of metastases represents the endpoint of many lethal events that only few tumour cells survive. Primary tumours contain cells with heterogeneous metastatic properties, and the outcome of metastasis depends on the interplay of tumour cells with various host factors. Collectively, then, our studies and most data reported by others have led us to conclude that metastasis is a highly selective process regulated by a number of mechanisms. This belief is contrary to the once widely accepted notion that neoplastic dissemination is the ultimate expression of cellular anarchy. In fact, suggesting that cancer metastasis is a selective process is a more optimistic view in terms of cancer therapy than the one that contends that tumour dissemination is an entirely random event. A selective biological process is regulated by the interaction of tumour cells with their host, and these complex interactions can be studied and manipulated. A better understanding of the complexity of the processes of tumour evolution, progression, and metastasis should lead to improvements in the treatment of cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2124977     DOI: 10.1111/j.1365-2362.1990.tb01889.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  13 in total

Review 1.  The role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cells.

Authors:  N Porther; M A Barbieri
Journal:  Small GTPases       Date:  2015-08-20

2.  Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.

Authors:  Alexander Darom; Ilias P Gomatos; Emmanuel Leandros; Emmu Chatzigianni; Dimitris Panousopoulos; Manousos M Konstadoulakis; George Androulakis
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

3.  Integrin-mediated entry into S phase of human gastric adenocarcinoma cells.

Authors:  T Udagawa; V L Hopwood; S Pathak; B W McIntyre
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

Review 4.  Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways.

Authors:  Henri H Versteeg; C Arnold Spek; Maikel P Peppelenbosch; Dick J Richel
Journal:  Mol Med       Date:  2004 Jan-Jun       Impact factor: 6.354

Review 5.  New insights into tumor-host interactions in lymphoma metastasis.

Authors:  V Umansky; V Schirrmacher; M Rocha
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

6.  Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors.

Authors:  B A Teicher; D Chatterjee; J T Liu; S A Holden; G Ara
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  DNA ploidy of primary hepatocellular carcinoma and pulmonary metastases.

Authors:  Y Yoshida; T Kanematsu; D Korenaga; T Sonoda; K Sugimachi
Journal:  Clin Exp Metastasis       Date:  1992-09       Impact factor: 5.150

8.  DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis.

Authors:  Xiaoling Zhou; Drazen B Zimonjic; Sang-Won Park; Xu-Yu Yang; Marian E Durkin; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

Review 9.  Imaging preclinical tumour models: improving translational power.

Authors:  Marion de Jong; Jeroen Essers; Wytske M van Weerden
Journal:  Nat Rev Cancer       Date:  2014-06-19       Impact factor: 60.716

10.  Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discovery.

Authors:  Mark A Marzinke; Caitlin H Choi; Li Chen; Ie-Ming Shih; Daniel W Chan; Hui Zhang
Journal:  Mol Cell Proteomics       Date:  2012-11-19       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.